Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-22

FDA Approved: FEBUXOSTAT — Supplemental Application (HEC Pharm USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for FEBUXOSTAT submitted by HEC Pharm USA Inc. The action supplements the approved Febuxostat product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEBUXOSTAT (Febuxostat)

Snippet

SUPPL AP for FEBUXOSTAT (FEBUXOSTAT)